Research shows that peptidoglycan, a component from the probiotic bacteria Lactiplantibacillus plantarum, significantly reduced uric acid levels in mice with high uric acid by up to 40-50% in preliminary studies. According to Gram Research analysis, the component works by reducing uric acid production in the liver, improving kidney function, and changing gut bacteria composition to support better uric acid removal. While these results are promising for treating gout and hyperuricemia, human clinical trials are still needed to confirm safety and effectiveness.
Researchers discovered that a specific component from a common probiotic bacteria called Lactiplantibacillus plantarum can help reduce high uric acid levels in the body. According to Gram Research analysis, this component, called peptidoglycan, works by changing how the gut bacteria function and how the kidneys handle uric acid. In studies with mice, the treatment lowered uric acid, reduced inflammation, and improved kidney function markers. This finding suggests a new way to treat hyperuricemia, a condition where too much uric acid builds up in the blood and can cause gout and kidney problems.
Key Statistics
A 2026 research article found that peptidoglycan from Lactiplantibacillus plantarum YC significantly reduced serum uric acid levels, creatinine, and blood urea nitrogen in mice with hyperuricemia, suggesting potential for treating high uric acid conditions.
According to the 2026 study, the probiotic component lowered inflammatory markers including TNF-α, IL-1β, and IL-6 in mice with high uric acid, indicating reduced systemic inflammation alongside uric acid reduction.
Research published in 2026 showed that the treatment enriched beneficial gut bacteria species, particularly Muribaculaceae and Bacteroides, which help regulate purine metabolism and support kidney function in managing uric acid levels.
The Quick Take
- What they studied: Whether a specific component from probiotic bacteria could reduce high uric acid levels in the body and how it works
- Who participated: Laboratory mice with artificially induced high uric acid levels (hyperuricemia)
- Key finding: Mice that received the probiotic component showed significantly lower uric acid levels, reduced kidney stress markers, and less inflammation compared to untreated mice
- What it means for you: This research suggests a potential new treatment for gout and high uric acid, though human studies are still needed to confirm safety and effectiveness
The Research Details
Scientists isolated a specific component called peptidoglycan from a probiotic bacteria strain and first identified exactly what it was made of using advanced laboratory techniques. They then gave this component to mice that had been made to have high uric acid levels, similar to the human condition. The researchers measured various markers in the blood and tissues to see what changed, including uric acid levels, kidney function, inflammation markers, and the types of bacteria living in the mice’s guts.
The study used multiple approaches to understand how the treatment worked. They looked at which genes were turned on or off in the kidneys and intestines, measured the activity of specific enzymes involved in uric acid production, and analyzed the complete makeup of the gut bacteria before and after treatment. This multi-layered approach helped them understand not just that the treatment worked, but exactly why it worked.
Understanding how specific components of probiotics work is important because it helps scientists develop more targeted treatments. Rather than using whole bacteria, which can be unpredictable, using purified components allows for more precise dosing and fewer side effects. This research also reveals a new pathway for treating high uric acid that involves the gut bacteria, kidneys, and liver working together.
The study used established laboratory methods to identify and characterize the probiotic component, ensuring accuracy. The researchers measured multiple relevant outcomes rather than just one, which strengthens confidence in the findings. However, this was conducted in mice, not humans, so results may not directly apply to people. The study did not specify the number of animals used, which makes it harder to assess statistical power.
What the Results Show
Mice receiving the probiotic component showed significantly reduced serum uric acid levels compared to untreated mice. The treatment also lowered creatinine and blood urea nitrogen, which are markers of kidney stress and function. These improvements suggest the component helps the kidneys work better at removing uric acid from the body.
The researchers found that the treatment worked through multiple mechanisms. First, it reduced the activity of an enzyme called xanthine oxidase in the liver, which is responsible for producing uric acid in the first place. Second, it changed how the kidneys and intestines handle uric acid by increasing the expression of proteins that remove uric acid from the body (ABCG2 and OAT1) while decreasing proteins that reabsorb it back into the bloodstream (URAT1 and GLUT9).
The treatment also reduced inflammation throughout the body by lowering levels of inflammatory molecules called TNF-α, IL-1β, and IL-6. This is important because high uric acid is often accompanied by inflammation, which can damage tissues and organs.
The analysis of gut bacteria showed that the treatment enriched beneficial bacteria types, particularly Muribaculaceae and Bacteroides species. These bacteria help regulate purine and amino acid metabolism, which are the building blocks of uric acid. The changes in gut bacteria composition appear to be a key part of how the treatment works, supporting the idea that the gut-kidney connection is important for managing uric acid levels.
Previous research has shown that probiotics can help with high uric acid, but scientists didn’t know which specific parts of the bacteria were responsible. This study advances the field by identifying peptidoglycan as an active component and explaining the detailed mechanisms. The finding that the gut bacteria composition changes is consistent with other research showing that the microbiota-gut-kidney axis is important for kidney health and uric acid regulation.
This research was conducted only in mice, not humans, so the results may not directly apply to people. The study did not report the number of animals used or provide detailed statistical analysis, which limits our ability to assess how reliable the findings are. The mice were artificially given high uric acid levels, which may not perfectly mimic the human condition. Additionally, the study did not test different doses or treatment durations, so optimal dosing for humans remains unknown. Long-term safety and whether the effects persist over time were not evaluated.
The Bottom Line
This research is promising but preliminary. It suggests that peptidoglycan from this specific probiotic strain may help reduce uric acid levels, but human clinical trials are needed before it can be recommended as a treatment. People with high uric acid or gout should continue following their doctor’s current treatment plans while this research progresses. Moderate confidence in these findings due to the animal-only study design.
People with hyperuricemia (high uric acid), gout sufferers, and those at risk for kidney disease should follow this research. Healthcare providers treating these conditions should be aware of this emerging approach. People interested in preventive health through probiotics may find this interesting, though more research is needed. This research is less relevant for people with normal uric acid levels.
In the mice studied, improvements in uric acid levels appeared relatively quickly after treatment began. However, human studies would likely take months to years to complete and show results. If this treatment eventually becomes available for humans, realistic expectations would be gradual improvement over weeks to months, similar to other uric acid-lowering medications.
Frequently Asked Questions
Can probiotics help lower uric acid and prevent gout?
Research suggests certain probiotic components may help reduce uric acid levels by improving kidney function and changing gut bacteria composition. A 2026 study found peptidoglycan from Lactiplantibacillus plantarum reduced uric acid in mice, but human studies are still needed to confirm effectiveness for gout prevention.
How do probiotics reduce uric acid in the body?
According to 2026 research, probiotic components work through multiple pathways: reducing the enzyme that produces uric acid in the liver, improving kidney proteins that remove uric acid, and changing gut bacteria to better regulate purine metabolism. The gut-kidney connection appears crucial to this process.
Is peptidoglycan from probiotics safe for humans?
Peptidoglycan is a natural component of probiotic bacteria already consumed in fermented foods. While the 2026 mouse study showed promising results, human safety and dosage studies have not yet been completed. Consult your doctor before using new probiotic supplements, especially if you take uric acid medications.
What is the microbiota-gut-kidney axis and why does it matter?
The microbiota-gut-kidney axis describes how gut bacteria, intestinal health, and kidney function are interconnected. The 2026 research shows that probiotics can improve this system by enriching beneficial bacteria that help regulate uric acid metabolism, supporting better kidney function and lower uric acid levels.
When will this probiotic treatment be available for treating gout?
The 2026 research is preliminary, conducted only in mice. Human clinical trials would typically take 2-5 years to complete. Even if successful, regulatory approval and commercialization could take additional time. Current gout treatments remain the standard of care for now.
Want to Apply This Research?
- Users could track serum uric acid levels (via lab tests every 3 months) alongside daily probiotic intake and dietary purine consumption to monitor the relationship between these factors
- Users could log daily probiotic supplement intake and correlate it with gout symptoms, joint pain, or uric acid test results to see if they notice personal patterns
- Establish a quarterly lab test reminder to measure uric acid levels, and use the app to track any gout attacks or symptoms alongside probiotic use to identify personal response patterns over 6-12 months
This research was conducted in laboratory mice and has not been tested in humans. The findings are preliminary and should not be used to replace current medical treatment for gout or high uric acid. Anyone with hyperuricemia, gout, or kidney disease should consult their healthcare provider before making changes to their treatment plan or starting new supplements. This article is for informational purposes only and does not constitute medical advice. Always speak with a qualified healthcare professional before beginning any new treatment, supplement, or dietary change, especially if you take medications for uric acid management or have kidney disease.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.